LMAT NASDAQ
LeMaitre Vascular, Inc.
1W: +0.5%
1M: +1.8%
3M: -19.1%
YTD: +4.5%
1Y: -5.8%
3Y: +73.6%
5Y: +60.1%
$83.79
-0.52 (-0.62%)
Pre-Market: $84.50 (+0.71, +0.85%)
Weekly Expected Move ±3.9%
$78
$81
$84
$88
$91
Credit Risk of going bust: lower than 67% of companies Debt: 9.0% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.71 (down 99.2%), LeMaitre Vascular, Inc. would be worth roughly what it owes.
Total debt $190.3M against a stock market value of $1.92B.
Distance to default 7.10 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $84.5M (short-term plus half of long-term), stock volatility 45.6%; Altman Z 7.37. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.71 (down 99.2%), LeMaitre Vascular, Inc. would be worth roughly what it owes.
Total debt $190.3M against a stock market value of $1.92B.
Distance to default 7.10 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $84.5M (short-term plus half of long-term), stock volatility 45.6%; Altman Z 7.37. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
15 relationships14
As Filer
counterparties named
1
As Counterparty
mentioned by others
3
Rel. Types
2021-07-16
Earliest Filing
2023-04-21
Latest Filing
target: 9
partner: 4
acquirer: 1
Counterparties (Filed by LMAT)
14 relationshipsCompanies named in LMAT's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| LeMaitre Vascular, Inc. | LMAT | acquirer | Purchaser in asset purchase agreement | 2021-09-01 | View |
| Anteris Technologies Ltd | AVR | target | Parent company of Seller Group | 2021-09-01 | View |
| Admedus Regen Pty Ltd | — | target | Member of Seller Group | 2021-09-01 | View |
| Admedus Biomanufacturing Pty Ltd | — | target | Member of Seller Group | 2021-09-01 | View |
| Admedus Investments Pty Limited | — | target | Member of Seller Group | 2021-09-01 | View |
| Admedus (NZ) Ltd | — | target | Member of Seller Group | 2021-09-01 | View |
| Admedus (Australia) Pty Ltd | — | target | Member of Seller Group | 2021-09-01 | View |
| Anteris Technologies Sàrl | — | target | Member of Seller Group | 2021-09-01 | View |
| Admedus (Singapore) Pte. Ltd. | — | target | Member of Seller Group | 2021-09-01 | View |
| Anteris Technologies Corporation | AVR | target | Member of Seller Group | 2021-09-01 | View |
| LeMaitre Vascular, Inc. | LMAT | partner | Company issuing shares in the offering | 2021-07-16 | View |
| Jefferies LLC | JEF | partner | Representative of the underwriters | 2021-07-16 | View |
| Stifel, Nicolaus & Company, Incorporated | — | partner | Representative of the underwriters | 2021-07-16 | View |
| Grant Thornton LLP | — | partner | Independent registered public accounting firm | 2021-07-16 | View |
Mentioned As Counterparty
1 mentionsOther companies that named LMAT in their SEC 8-K filings.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-15 | Officer/Director Change | View | |
| 2026-08-04 | Earnings Release; Exhibits | View | |
| 2026-06-05 | Shareholder Vote | View | |
| 2026-05-05 | Earnings Release; Exhibits | View | |
| 2026-04-14 | Officer/Director Change; Other Events | View | |
| 2026-02-25 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-07 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-03 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-01 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-02-27 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-02-13 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2024-12-19 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2024-12-17 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-12-16 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-10-31 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-08-26 | Departure/Election of Directors; Appointment of Officers | View | |
| 2024-08-01 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-05-02 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR